BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17922787)

  • 1. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
    Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
    BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An autopsy specimen study of benign hyperplastic nodules in the peripheral zone of the prostate].
    Liu X; Tang J; Yang JC; Zhang Y; Shi HY
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):307-10. PubMed ID: 18481420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced transrectal ultrasound for assessing vascularization of hypoechoic BPH nodules in the transition and peripheral zones: comparison with pathological examination.
    Yang JC; Tang J; Li Y; Fei X; Shi H
    Ultrasound Med Biol; 2008 Nov; 34(11):1758-64. PubMed ID: 18524461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.
    Shi YF; Yu DJ; Jiang CY; Wang XJ; Zhu YP; Zhao RZ; Lv Z; Sun XW
    Prostate; 2018 Feb; 78(3):193-201. PubMed ID: 29171041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins.
    Meikle AW; Stephenson RA; Lewis CM; Middleton RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):571-5. PubMed ID: 9024256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
    Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
    Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia.
    Tsurusaki T; Aoki D; Kanetake H; Inoue S; Muramatsu M; Hishikawa Y; Koji T
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1333-40. PubMed ID: 12629127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative morphometry of hyperplastic hypoechoic nodules in the prostatic outer gland].
    Li X; Wang N; Shi HY; Zhang Y; Fu XS; Li JL; Xu JH; Tang J
    Zhonghua Nan Ke Xue; 2005 Feb; 11(2):91-3. PubMed ID: 15755023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell apoptosis and proliferation in the transition and peripheral zones in human prostate].
    Sun HB; Xia SJ
    Zhonghua Nan Ke Xue; 2007 Feb; 13(2):110-3. PubMed ID: 17345763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels.
    Lepor H; Wang B; Shapiro E
    Urology; 1994 Aug; 44(2):199-205. PubMed ID: 7519380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
    Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland.
    Oyen RH; Van de Voorde WM; Van Poppel HP; Brys PP; Ameye FE; Franssens YM; Baert AL; Baert LV
    Radiology; 1993 Dec; 189(3):707-11. PubMed ID: 7694310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N; Tu H; Jacobs SC
    Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate.
    Zhao FJ; Han BM; Yu SQ; Xia SJ
    Asian J Androl; 2009 Mar; 11(2):176-82. PubMed ID: 19122679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
    Berger AP; Deibl M; Halpern EJ; Lechleitner M; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer A; Bartsch G; Frauscher F
    Diabetologia; 2005 Apr; 48(4):784-9. PubMed ID: 15756540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
    Sakai I; Harada K; Hara I; Eto H; Miyake H
    BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
    Erbersdobler A; Fritz H; Schnöger S; Graefen M; Hammerer P; Huland H; Henke RP
    Eur Urol; 2002 Jan; 41(1):40-6. PubMed ID: 11999464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.